PMA supplement
P060027 S027: OVATIO CRT & SITUS OTW LV
FDA PMA supplement · Normal 180 Day Track No User Fee · MicroPort CRM S.r.l.
Key facts
| Original PMA | P060027 |
|---|---|
| Supplement number | S027 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol - OSB |
| Trade name | OVATIO CRT & SITUS OTW LV |
| Generic name | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) |
| Applicant | MicroPort CRM S.r.l. |
| Product code | NIK |
| Received date | Jul 16, 2010 |
| Decision date | Sep 14, 2010 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: